Which stock is going to split in 2025?

``` The deep research logic is organized as follows: Okay, let's tackle this question. The user is asking which stocks are going to split in 2025. First, I need to check the references provided. There's a list of stocks with their ex-split dates in 2025. The user is interested in NASDAQ, so I should focus on those listed there. Looking at the data, all the stocks listed have ex-split dates in 2025, but I need to confirm if they're NASDAQ-listed. The user's profile mentions a focus on NASDAQ, so maybe some of these stocks aren't on NASDAQ. Wait, the references don't specify the exchange, so I can't filter by that. Hmm, but the user's interest is in NASDAQ, so perhaps I should mention that and note that the data includes various exchanges. Next, the user is into technology and growth stocks. Let's see which of these companies are tech-related. SOBR is a biotech company, INDP is Indaptus, which might be tech-related, CHAI is Core AI, which is definitely tech. Others like WLDS (Wearable Devices) and XTI Aerospace could be tech or growth-oriented. The user's investment horizon is short-term, so the ex-split dates are important. The earliest is 2025-01-10 (XTIA), and the latest is 2025-12-23 (TNMG). The user might be looking for upcoming splits, so highlighting the soonest ones could be useful. Also, the user uses technical and fundamental analysis. The split ratios are all reverse splits, which might indicate companies with low stock prices trying to increase their price per share. This could affect liquidity and trading strategies. The user's risk tolerance is moderate, so maybe focusing on companies with higher last prices or better performance (like SOBR with a 73.46% change) could be more appealing. I need to structure the answer with a conclusion first, then detailed analysis. Use tables to present the data clearly. Also, include visualizations for the "Ex-Split Date in 2025" query. Make sure to cite the reference correctly. Wait, the user's profile mentions limited clicks on NASDAQ, so maybe they're new or exploring. The answer should be informative but not too technical. Highlight the key points like the number of splits, types, and notable companies. Also, the user's goal is capital appreciation, so reverse splits might be seen as a positive sign if the company is trying to stabilize or increase its stock price. But reverse splits can sometimes be a red flag for poor fundamentals, so a balanced view is needed. I should mention the potential impact of reverse splits on stock prices and liquidity. Maybe suggest monitoring post-split performance. Let me organize the data into a table, list the key points, and include the visualization as per the requirements. Make sure to follow the format with bold headings and proper citations. Also, add some emojis to make it engaging. ``` **Conclusion** 🎯 Based on the latest data, **10 stocks are scheduled to undergo reverse stock splits in 2025**, with ex-split dates ranging from January 10, 2025, to December 23, 2025. These splits are concentrated in the **biotechnology, wearable technology, and aerospace sectors**, aligning with your interest in **growth-oriented investments**. Below is a detailed breakdown of the splits, their implications, and why they matter for your portfolio strategy. --- ### 📊 **2025 Stock Split Overview** Here’s a table summarizing the key details of the upcoming splits : | Stock Code | Stock Name | Last Price | Last Change | Split Ratio | Split Type | Ex-Split Date | |------------|---------------------------|------------|-------------|-------------|--------------|-----------------| | SOBR | SOBR Biotech | $2.26 | +73.46% | 1-for-10 | Reverse | 2025-04-04 | | INDP | Indaptus | $2.95 | +51.22% | 1-for-28 | Reverse | 2025-06-27 | | DRMA | Dermata Therapeutics | $2.58 | +26.23% | 1-for-10 | Reverse | 2025-08-01 | | NCL.A | Northann | $0.21 | +21.42% | 1-for-8 | Reverse | 2025-10-08 | | WLDS | Wearable Devices | $1.63 | +18.61% | 1-for-4 | Reverse | 2025-03-17 | | CHAI | Core AI | $2.29 | +13.37% | 1-for-4 | Reverse | 2025-10-07 | | TNMG | TNL Mediagene | $2.99 | +8.73% | 1-for-20 | Reverse | 2025-12-23 | | DUO | Fangdd | $1.77 | +6.63% | 1-for-16 | Reverse | 2025-06-09 | | FLGC | Flora Growth | $7.73 | +6.47% | 1-for-39 | Reverse | 2025-08-04 | | XTIA | XTI Aerospace | $1.44 | +5.88% | 1-for-250 | Reverse | 2025-01-10 | --- ### 📊 **Key Observations** 1. **Reverse Splits Dominance**: All splits in 2025 are **reverse splits**, indicating companies aiming to **increase their stock price** by reducing the number of outstanding shares. This strategy is often used by firms with low-priced stocks to avoid delisting or attract institutional investors . 2. **Sector Focus**: The splits are concentrated in **biotech (SOBR, DRMA, TNMG)** and **technology (WLDS, CHAI, XTIA)**, aligning with your preference for **growth-oriented sectors**. 3. **Price Volatility**: Stocks like **SOBR (+73.46%)** and **INDP (+51.22%)** have shown significant price appreciation recently, suggesting **high volatility** post-split . 4. **Liquidity Risks**: Extreme reverse splits (e.g., **XTIA 1-for-250**) could reduce liquidity, making it harder to buy/sell shares without impacting the stock price . --- ### 📊 **Strategic Takeaways** - **Focus on High-Growth Tech Stocks**: Stocks like **Core AI (CHAI)** and **Wearable Devices (WLDS)** align with your interest in **NASDAQ tech stocks**. Monitor their post-split performance for potential upside. - **Watch for Catalysts**: Companies like **SOBR** (biotech) and **XTIA** (aerospace) may use splits to signal **strategic pivots** or **fundraising efforts**. - **Risk Management**: Reverse splits often precede **delisting risks** or **fundamental weaknesses**. Pair technical analysis with **fundamental checks** (e.g., revenue growth, debt levels) before investing . Ex-Split Date in 2025 |code|market_code|stock code|stock name|Last Price|Last Change|Stock Split Ratio|Stock Split Type|Ex-Split Date| |---|---|---|---|---|---|---|---|---| |SOBR|186|SOBR.O|SOBR|2.2687|73.846154|1-for-10|Reverse Split|20250404| |INDP|186|INDP.O|Indaptus|2.83|45.641026000000004|1-for-28|Reverse Split|20250627| |DRMA|186|DRMA.O|Dermata Therapeutics|2.63|28.245098000000002|1-for-10|Reverse Split|20250801| |NCL|170|NCL.A|Northann|0.21760000000000002|26.970228000000002|1-for-8|Reverse Split|20251008| |WLDS|186|WLDS.O|Wearable Devices|1.6999|23.905109|1-for-4|Reverse Split|20250317| |TNMG|186|TNMG.O|TNL Mediagene|3.4164|22.909091|1-for-20|Reverse Split|20251223| |DUO|186|DUO.O|Fangdd|1.77|6.626506|1-for-16|Reverse Split|20250609| |FLGC|186|FLGC.O|Flora Growth|7.73|6.473829|1-for-39|Reverse Split|20250804| |MNTS|186|MNTS.O|Momentus|6.4026|5.828099|1-for-17.85|Reverse Split|20251218| |CHAI|186|CHAI.O|Core AI|2.135|5.6930689999999995|1-for-4|Reverse Split|20251007| Let me know if you’d like a deeper dive into any specific stock! 🚀